METROPOLITAN LIFE INSURANCE CO/NY - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 272 filers reported holding BLUEBIRD BIO INC in Q4 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$17,054
-7.6%
5,6100.0%0.00%0.0%
Q2 2023$18,457
+3.5%
5,6100.0%0.00%0.0%
Q1 2023$17,840
-49.9%
5,610
+9.1%
0.00%
-50.0%
Q4 2022$35,596
+20.4%
5,144
+10.1%
0.00%
+100.0%
Q3 2022$29,567
+270.6%
4,671
+142.4%
0.00%
Q2 2022$7,978
-63.5%
1,927
-57.3%
0.00%
-100.0%
Q1 2022$21,869
-87.9%
4,509
-75.0%
0.00%
-50.0%
Q4 2021$180,519
-49.6%
18,070
-3.6%
0.00%
-60.0%
Q3 2021$358,389
-40.2%
18,7540.0%0.01%
-37.5%
Q2 2021$599,753
+588.1%
18,754
+548.7%
0.01%
+700.0%
Q1 2021$87,164
-31.9%
2,891
-2.3%
0.00%
-50.0%
Q4 2020$128,036
-21.5%
2,959
-2.2%
0.00%
-33.3%
Q3 2020$163,199
-11.6%
3,0250.0%0.00%0.0%
Q2 2020$184,646
+200.9%
3,025
+126.6%
0.00%
+200.0%
Q1 2020$61,357
-47.6%
1,3350.0%0.00%
-50.0%
Q4 2019$117,146
-4.1%
1,335
+0.3%
0.00%0.0%
Q3 2019$122,212
-69.5%
1,331
-57.8%
0.00%
-71.4%
Q2 2019$401,062
-20.8%
3,153
-2.0%
0.01%
-22.2%
Q1 2019$506,131
+55.5%
3,217
-2.0%
0.01%
+28.6%
Q4 2018$325,475
-32.2%
3,281
-0.2%
0.01%
-22.2%
Q3 2018$480,048
-99.9%
3,288
+4.8%
0.01%
+12.5%
Q2 2018$492,194,000
-81.2%
3,136
-79.5%
0.01%
-78.4%
Q1 2018$2,615,207,000
+99224.2%
15,316
+3.6%
0.04%
+5.7%
Q4 2017$2,633,000
-37.2%
14,782
-51.6%
0.04%
+34.6%
Q3 2017$4,192,000
+42.1%
30,518
+8.6%
0.03%
+30.0%
Q2 2017$2,951,000
+15.6%
28,0900.0%0.02%
+11.1%
Q1 2017$2,553,000
+45.1%
28,090
-1.5%
0.02%
+38.5%
Q4 2016$1,759,000
-2.0%
28,505
+7.6%
0.01%0.0%
Q3 2016$1,795,000
+53.3%
26,488
-2.0%
0.01%
+44.4%
Q2 2016$1,171,000
+927.2%
27,042
+908.7%
0.01%
+800.0%
Q1 2016$114,000
-33.7%
2,6810.0%0.00%0.0%
Q4 2015$172,000
-22.9%
2,681
+2.7%
0.00%
-50.0%
Q3 2015$223,000
-44.7%
2,610
+9.0%
0.00%
-33.3%
Q2 2015$403,000
-82.5%
2,395
-87.4%
0.00%
-82.4%
Q1 2015$2,298,000
+45.2%
19,027
+10.2%
0.02%
+54.5%
Q4 2014$1,583,000
+155.7%
17,2610.0%0.01%
+175.0%
Q3 2014$619,000
+7.5%
17,261
+15.6%
0.00%0.0%
Q2 2014$576,000
+164.2%
14,927
+84.6%
0.00%
+100.0%
Q3 2013$218,0008,0860.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 5,910,687$24,470,0003.71%
Monaco Asset Management SAM 306,142$1,267,0000.55%
Parametrica Management Ltd 90,105$374,0000.41%
Kamunting Street Capital Management, L.P. 55,200$229,0000.31%
Birchview Capital, LP 98,000$406,0000.30%
Kamunting Street Capital Management, L.P. 35,000$145,0000.20%
PDT Partners, LLC 519,477$2,151,0000.19%
Graham Capital Management, L.P. 781,912$3,237,0000.13%
CAXTON ASSOCIATES LP 220,154$911,0000.09%
Baker Brothers Advisors 2,499,715$10,349,0000.06%
View complete list of BLUEBIRD BIO INC shareholders